Five Things to Watch as J&J Covid Vaccine Gets CDC Panel Review

Experts meet Friday to discuss side effects, recommendations
Vaccine on hold for 10 days after rare blood clotting seen

J&J Pause Was Right Decision, FDA Advisory Panel Member Says

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Angelica Peebles

April 23, 2021 at 9:00 AM UTC

This article is for subscribers only.

Vaccine experts will meet Friday to review Johnson & Johnson’s Covid-19 shot, which has been on hold for 10 days after several cases of rare and serious blood clots.

The panel of experts, called the Advisory Committee on Immunization Practices, advises the Centers for Disease Control and Prevention. Its 15 voting members will review the evidence and debate whether J&J’s shot should again be used in the U.S., perhaps with new warnings or restrictions, after federal health officials urged pausing use of the shot.